From suboptimal outreach to member trust barriers, new market research shows health plans’ greatest challenges

From suboptimal outreach to member trust barriers, new market research shows health plans’ greatest challenges

The FDA’s approval of a nasal mist flu vaccine for at-home use represents more than just a convenient alternative to the traditional flu shot — it marks a significant shift in healthcare delivery, moving toward a decentralized model where patients can self-administer care from the comfort of their own homes.  

A Big Month in the Health Tech World

A Big Month in the Health Tech World

While the return to in-person conferences has been measured, this month brought a one-two punch with the introduction of ViVE 2022 the week prior to HIMSS22. Each year, the HIMSS Global Health Conference gives attendees throughout the health ecosystem the opportunity to share their industry knowledge, connect with other professionals, and have deep conversations about the future state of healthcare.